Metabolic considerations in atrial fibrillation ― Mechanistic insights and therapeutic opportunities

Masahide Harada, Jonathan Melka, Yoshihiro Sobue, Stanley Nattel

研究成果: Review article

9 引用 (Scopus)

抜粋

Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice and is associated with morbidity and mortality. Over the past 2 decades, there have been major advances in understanding AF pathophysiology, but important knowledge gaps, particularly about targetable basic mechanisms, remain. Recent metabolomic and proteomic studies have shown changes in the expression of molecules involved in metabolic pathways in human and experimental AF, indicating a role for metabolic alterations in AF pathophysiology. AF is characterized by irregular high-frequency excitation and contraction that affect atrial energy demands, circulation and oxygen supply, and change the balance between metabolic demand and supply, causing metabolic stress. Here, we review the information available about AF-induced metabolic changes and their pathophysiological contribution. We also discuss the possibilities of developing novel therapeutic strategies that act by modulating cardiac metabolic processes during AF.

元の言語English
ページ(範囲)1749-1757
ページ数9
ジャーナルCirculation Journal
81
発行部数12
DOI
出版物ステータスPublished - 01-01-2017

    フィンガープリント

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

これを引用